Gamma Knife
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
In medicine, the Leksell Gamma Knife is a neurosurgical device used to treat brain tumors with radiation therapy. The device was invented by Lars Leksell, a Swedish neurosurgeon, in 1967 at the Karolinska Institute in Sweden.
The Leksell Gamma Knife device contains 201 cobalt-60 sources of approximately 30 curies (1.1 TBq) each, placed in a circular array in a heavily shielded assembly. The device aims gamma radiation through a target point in the patient's brain. The patient wears a specialized helmet that is surgically fixed to their skull so that the brain tumor remains stationary at target point of the gamma rays. A killing dose of radiation is thereby sent through the tumor in one treatment session, while all surrounding brain tissues receive less than a killing dose.
Efficacy and risk
The Gamma Knife has proved effective for thousands of patients with benign or malignant brain tumors, vascular malformations such as an arteriovenous malformation (AVM), pain or other functional problems. The procedure is less invasive than alternative surgeries such as micro-decompression. For treatment of trigeminal neuralgia the procedure may be used repeatedly on patients. Leksell Gamma Knife has been reviewed in over 2,000 publications with long-term follow-up studies on patients all demonstrating high clinical success rates.[citation needed]
Ultimately, consideration for Gamma Knife radiosurgery treatment is contingent upon the patient's diagnosis, medical history and the case's overall severity upon consultation. In some instances, neurosurgeons will consider treatment for patients with metastatic disease, the elderly and whose life span will not exceed fifteen years, as well as those with inoperable lesions.
The risks of Gamma Knife radiosurgery treatment include but are not limited to radiation necrosis, secondary malignancy caused by the radiation (ie: formation of new tumor), hemorrhage, infection from the placement of the stereotactic headframe, paralysis and death.
Performance
 |
This article or section is written like an advertisement. Please help rewrite this article from a neutral point of view. Mark blatant advertising for speedy deletion, using {{db-spam}}. |
Leksell Gamma Knife guarantees accuracy to better than 0.5mm and has found the actual achievable accuracy to be 0.15mm.[citation needed] The new Leksell Gamma Knife Perfexion system provides a larger treatment volume, allowing more sites of treatment.
- Nearly half a million patients treated over 30+ years[1]
- As a form of radiosurgery, Gamma Knife is covered by most insurance providers[2]
Leksell Gamma Knife is the gold standard for stereotactic neurosurgery against which all other systems are compared.[citation needed][3]
See also
- Brain Tumor
- External beam radiotherapy
- Horsley-Clarke apparatus
- Minimally invasive procedure
- Neurosurgery
- Radiosurgery
- Radiation therapy
- Robotic surgery
- Stereotactic surgery
- Elekta, manufacturer of the Leksell Gamma Knife
References
- Sheehan et al. Gamma knife surgery-induced meningioma. Report of two cases and review of the literature. J Neurosurg. 2006 Aug;105(2):325-9.
- Rowe et al. Risk of Malignancy after Gamma Knife Radiosurgery, Neurosurgery. 60(1):60-66, January 2007.
External links
- Clinical Bibliography - Bibliography of published papers regarding Gamma Knife surgery. Includes downloadable bibliographies for various conditions.
- Elekta's International Patient Site
- Elekta Official Web Site
- International RadioSurgery Association
- Gamma Knife History from the University of Virginia
- Cross-sectional view of Gamma Knife (Model C)
- How Gamma Knife Works (Video)
- Leksell Gamma Knife Society (For clinicians)
- Gamma Knife Surgery at the Neurologic & Orthopedic Hospital of Chicagode:Gamma-Knife
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
